The dengue virus non-structural 1 protein: risks and benefits (2014)
- Authors:
- USP affiliated authors: BOSCARDIN, SILVIA BEATRIZ - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1016/j.virusres.2014.01.001
- Subjects: MICROBIOLOGIA; PARASITOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Virus Research
- ISSN: 1872-7492
- Volume/Número/Paginação/Ano: v. 181, p. 53-60, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AMORIM, Jaime Henrique et al. The dengue virus non-structural 1 protein: risks and benefits. Virus Research, v. 181, p. 53-60, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.virusres.2014.01.001. Acesso em: 13 fev. 2026. -
APA
Amorim, J. H., Alves, R. P. dos S., Boscardin, S. B., & Ferreira, L. C. de S. (2014). The dengue virus non-structural 1 protein: risks and benefits. Virus Research, 181, 53-60. doi:10.1016/j.virusres.2014.01.001 -
NLM
Amorim JH, Alves RP dos S, Boscardin SB, Ferreira LC de S. The dengue virus non-structural 1 protein: risks and benefits [Internet]. Virus Research. 2014 ; 181 53-60.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.virusres.2014.01.001 -
Vancouver
Amorim JH, Alves RP dos S, Boscardin SB, Ferreira LC de S. The dengue virus non-structural 1 protein: risks and benefits [Internet]. Virus Research. 2014 ; 181 53-60.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.virusres.2014.01.001 - CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein
- Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
- A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses
- Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors
- Parenteral adjuvant effects of an enterotoxigenic Escherichia coli natural heat-labile toxin variant
- Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses
- Dendritic cells in tolerance and immunity against pathogens
- Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii
- Adjuvants: classification, Modus Operandi, and licensing.
Informações sobre o DOI: 10.1016/j.virusres.2014.01.001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
